New tools for studying GlcNAc biology

研究 GlcNAc 生物学的新工具

基本信息

  • 批准号:
    9814544
  • 负责人:
  • 金额:
    $ 50.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The goal of this project is to develop accessible and effective methods to monitor the levels and interaction partners of GlcNAc-containing glycoconjugates. N-acetylglucosamine (GlcNAc) is a monosaccharide found in many classes of mammalian glycoconjugates. Addition of GlcNAc to serine and threonine residues forms the intracellular O-GlcNAc modification, and GlcNAc is also incorporated into many extracellular glycoconjugates including N-linked glycans and GalNAc-type glycans. Incorporation of GlcNAc into glycoconjugates is catalyzed by the activity of N-acetylglucosaminyltransferases (GlcNAc-transferases) that transfer GlcNAc from the donor UDP-GlcNAc to (glyco)protein and (glyco)lipid acceptors. UDP-GlcNAc is produced through the nutrient-sensing hexosamine biosynthetic pathway, which integrates information about carbohydrate, protein, lipid, and nucleotide availability. UDP-GlcNAc levels regulate production of key glycan structures, namely O- GlcNAcylation and N-linked glycan branching, which in turn control essential signal transduction pathways. Thus, GlcNAc-containing glycans represent a crucial link between metabolic state and cellular signaling. However, cell-based methods to characterize the levels and interaction partners of these molecules remain inadequate. Aim 1 will deliver non-invasive, non-perturbing fluorescent and luminescent reporters of intracellular O-GlcNAc levels. This Aim builds on the discovery that splicing of the O-GlcNAc transferase (OGT) transcript responds rapidly to changes in O-GlcNAc levels. Aims 2-4 improve upon previously reported photocrosslinking sugar technology, in which the diazirine photoactivatable crosslinking group is installed on GlcNAc residues in living cells. Aim 2 will make this technology easier to use by simplifying the reagents, improving crosslinking yield, and facilitating purification of crosslinked complexes. Aim 3 will make this technology broader in scope by introducing photocrosslinking GlcNAc into additional classes of glycoconjugates, including N-linked glycans. Aim 4 will make the technology more powerful by developing a mass spectrometry strategy to identify not only the identity of the sites of the binding partners, but also the sites of crosslinking. The mass spectrometry-based approach to crosslinking analysis will capture molecular details of O-GlcNAc-dependent interactions that occur in living cells. The reagents and methods developed in this proposal will be shared with other research groups to enable study of a wide variety of O-GlcNAcylation and N-glycosylated proteins with diverse biological functions. The proposed work prioritizes approaches that are simple to implement and make use of “off-the-shelf” reagents and procedures. Making these methods available to the broad biomedical community is significant because dysregulation of GlcNAc-containing glycoconjugates is associated with multiple disease states including diabetes, neurodegenerative disease, and cancer.
项目总结/摘要 该项目的目标是开发可访问和有效的方法来监测水平和互动 含有GlcNAc的糖缀合物的配偶体。N-乙酰葡萄糖胺(GlcNAc)是一种单糖,存在于 许多种类的哺乳动物糖缀合物。将GlcNAc添加到丝氨酸和苏氨酸残基形成了GlcNAc。 细胞内的O-GlcNAc修饰,并且GlcNAc也掺入许多细胞外的糖缀合物中 包括N-连接聚糖和GalNAc型聚糖。将GlcNAc掺入糖缀合物中是 由N-乙酰葡糖胺基转移酶(GlcNAc-转移酶)的活性催化, 将供体UDP-GlcNAc转化为(糖)蛋白和(糖)脂质受体。UDP-GlcNAc是通过 营养传感己糖胺生物合成途径,它整合了碳水化合物,蛋白质, 脂质和核苷酸可用性。UDP-GlcNAc水平调节关键聚糖结构的产生,即O- GlcNAc酰化和N-连接聚糖分支,这反过来又控制着重要的信号转导途径。 因此,含GlcNAc的聚糖代表了代谢状态和细胞信号传导之间的关键联系。 然而,基于细胞的方法来表征这些分子的水平和相互作用伴侣仍然存在 不足Aim 1将提供非侵入性,非干扰性的荧光和发光报告基因, 细胞内O-GlcNAc水平。这一目标建立在O-GlcNAc转移酶的剪接 (OGT)转录物迅速响应O-GlcNAc水平的变化。目标2-4比以前报告的有所改进 光交联糖技术,其中二氮丙环可光活化的交联基团安装在 活细胞中的GlcNAc残基。目标2将通过简化试剂使这项技术更容易使用, 提高了交联产率,有利于交联复合物的纯化。目标3将使这个 通过将光交联GlcNAc引入到其他类别的 糖缀合物,包括N-连接的聚糖。Aim 4将通过开发一种 质谱分析策略,以确定不仅结合配偶体的位点的身份,而且还 交联位点。基于质谱的交联分析方法将捕获分子 活细胞中发生的O-GlcNAc依赖性相互作用的详细信息。开发的试剂和方法 这一建议将与其他研究小组分享,以便能够对各种O-GlcNAc酰化进行研究 和具有多种生物学功能的N-糖基化蛋白质。拟议的工作优先考虑的方法, 易于实施,并且使用“现成的”试剂和程序。使这些方法 广泛的生物医学界可用的是重要的,因为含有GlcNAc的 糖缀合物与多种疾病状态相关,包括糖尿病、神经退行性疾病和 癌

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer J Kohler其他文献

Transcriptional Control of Gene Expression By O-Glcnacylation during Erythropoiesis
  • DOI:
    10.1182/blood-2024-201756
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Kenneth R Peterson;Matthew P Parker;Aspin Denson;Will Brautman;Nick Lowe;Halyna Fedosyuk;Lesya V Novikova;Jeffrey A Thompson;Jennifer J Kohler;Chad Slawson
  • 通讯作者:
    Chad Slawson
A shift for the O-GlcNAc paradigm
O-GlcNAc 范式的转变
  • DOI:
    10.1038/nchembio.429
  • 发表时间:
    2010-09-01
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Jennifer J Kohler
  • 通讯作者:
    Jennifer J Kohler

Jennifer J Kohler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer J Kohler', 18)}}的其他基金

Function and regulation of epithelial glycosylation
上皮糖基化的功能和调节
  • 批准号:
    10621189
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMA
剖析和瞄准 GALNT14 在高风险骨肉瘤中的作用
  • 批准号:
    10761850
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMA
剖析和瞄准 GALNT14 在高风险骨肉瘤中的作用
  • 批准号:
    10363579
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
Function and regulation of epithelial glycosylation
上皮糖基化的功能和调节
  • 批准号:
    10414154
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
Chemistry-Biology Interface T32
化学-生物接口 T32
  • 批准号:
    10409763
  • 财政年份:
    2019
  • 资助金额:
    $ 50.38万
  • 项目类别:
Chemistry-Biology Interface T32
化学-生物接口 T32
  • 批准号:
    10171593
  • 财政年份:
    2019
  • 资助金额:
    $ 50.38万
  • 项目类别:
New tools for studying GlcNAc biology
研究 GlcNAc 生物学的新工具
  • 批准号:
    10187532
  • 财政年份:
    2019
  • 资助金额:
    $ 50.38万
  • 项目类别:
Chemistry-Biology Interface T32
化学-生物接口 T32
  • 批准号:
    10632125
  • 财政年份:
    2019
  • 资助金额:
    $ 50.38万
  • 项目类别:
Discovery of small molecule inhibitors of GalNAc-type O-linked glycosylation
GalNAc 型 O-连接糖基化小分子抑制剂的发现
  • 批准号:
    9763582
  • 财政年份:
    2018
  • 资助金额:
    $ 50.38万
  • 项目类别:
Photocrosslinking probes to discover glycan-dependent interactions
光交联探针发现聚糖依赖性相互作用
  • 批准号:
    9166533
  • 财政年份:
    2016
  • 资助金额:
    $ 50.38万
  • 项目类别:

相似海外基金

Reactions of Alkynes with Metal-Coordinated Phosphenium Ions
炔烃与金属配位磷离子的反应
  • 批准号:
    573824-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
    University Undergraduate Student Research Awards
Exploring the missing reactivity of heteroatom-substituted alkynes
探索杂原子取代的炔烃缺失的反应性
  • 批准号:
    559671-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
LEAPS-MPS: Developing a Spectroscopic Map for Terminal Alkynes
LEAPS-MPS:开发末端炔烃的光谱图
  • 批准号:
    2213339
  • 财政年份:
    2022
  • 资助金额:
    $ 50.38万
  • 项目类别:
    Standard Grant
Development of Synthetic Methods for Hetero-fused pi-Conjugated Compounds Based on Trans-Addition to Alkynes
基于炔烃反式加成的异稠合π共轭化合物的合成方法研究进展
  • 批准号:
    21K05061
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Enantioselective Carboalumination of Alkenes and Alkynes Catalyzed by Rare-Erath Metal Catalysts
稀土金属催化剂催化烯烃和炔烃对映选择性碳铝化反应的研究进展
  • 批准号:
    21F21334
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
  • 批准号:
    10544730
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
  • 批准号:
    10320911
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
Development of beta-carbon elimination reactions of alkynes from unstrained vinyl complexes
无应变乙烯基配合物中炔烃的β-碳消除反应的进展
  • 批准号:
    21K05101
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reactions of Alkynes with Metal-Coordinated Phosphenium Ions
炔烃与金属配位磷离子的反应
  • 批准号:
    563146-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
    University Undergraduate Student Research Awards
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
  • 批准号:
    10581995
  • 财政年份:
    2021
  • 资助金额:
    $ 50.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了